TOPLINE: Mental health disorders increase the likelihood of developing chronic diabetic complications and vice versa across all age groups in patients with type 1 diabetes (T1D) […]

TOPLINE: Rates of major adverse cardiovascular events do not differ significantly among individual biologics used for psoriasis or psoriatic arthritis (PsA), a database analysis finds.  METHODOLOGY: […]

TOPLINE: Patients with metastatic hormone-sensitive prostate cancer and baseline bone pain at diagnosis have worse overall survival compared to those without bone pain, a post hoc […]

TOPLINE: More gastrointestinal and nervous symptom adverse events (AEs) are linked to apremilast than deucravacitinib, which is associated with more cutaneous AEs, according to a retrospective […]

TOPLINE: Children whose mothers have a hypertensive disorder in pregnancy (HDP) may have an increased risk for strabismus, including exophoria and intermittent exotropia, new research shows. […]

TOPLINE: A study reveals nearly a quarter of patients treated with teprotumumab for thyroid eye disease require re-treatment within a year, and older patients are more […]

TOPLINE: In a single-center study, shifting the timing of nutritional insulin from pre- to post-prandial reduced the risk for hypoglycemia without affecting rates of severe hyperglycemia […]

TOPLINE: Researchers identified diverse gut microbial features linked to type 2 diabetes (T2D), suggesting the gut microbiome’s significant role in its pathogenesis and potential for diagnostic […]

TOPLINE: Topical delgocitinib, a pan-Janus kinase inhibitor, was well tolerated and reduced the severity and symptoms of disease in patients with moderate to severe chronic hand […]